Center News
Dr. Denise Galloway, head of the Program in Cancer Biology in the Human Biology and Public Health Sciences divisions, will speak at the next Perspectives in Science seminar, Thursday, Feb. 15, at 4:30 p.m. in Pelton Auditorium. Her presentation, "Human Papillomaviruses and Cervical Cancer: 25 years from Discovery to Vaccine," is the second talk in the 2006-07 seminar series.
Groundbreaking researcherBreakthrough research from Galloway and colleagues laid the groundwork for a cervical-cancer vaccine associated with the human papillomavirus. Cervical cancer is the leading cause of cancer deaths in women worldwide. Galloway and researchers in Australia and at the National Institutes of Health accomplished the critical step of getting a key viral gene to assemble into particles that look like HPV, the basis of the vaccine. In her 29 years at the Center, Galloway contributed to seminal discoveries that established a link between papillomaviruses and cancer. Her overriding interest in studying HPV has been to better understand cell-cycle disruptions.
While the seminar is open to all, the content will be scientifically technical. Dr. Shirley Ann Jackson, president of Rensselaer Polytechnic Institute and former chairman of the U.S. Nuclear Regulatory Commission, will speak at the final seminar of the series on April 12.
